Erin Cox, Head of Investor Relations
Forward Health Communications, Inc.
PhaseRx is a biopharmaceutical company developing a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. PhaseRx expert scientists are passionately committed to making a positive social impact by reducing serious medical problems and fatalities caused by these rare diseases.
410 West Harrison Street
Seattle WA 98119